For further information, contact the MBL Communications Office at (508) 289-7423 or e-mail us at comm@mbl.edu

For Immediate Release: February 2, 2009
Contact: Andrea Early, 508-289-7139; aearly@mbl.edu

		Robert H. Ament is a graduate of Wesleyan University and the University of Pennsylvania Law School, and co-founded the law firm of Ament & Ament in 1981. He works with clients primarily in the zoning and permitting process for real estate on Cape Cod. Ament has been a member of the MBL’s Whitman Society since 2000, and resides in Falmouth, Massachusetts.
		L. Patrick Gage is a veteran in the pharmaceutical and biotech fields. After a successful career in molecular genetics research, he moved into pharmaceutical research at Hoffmann-La Roche where he was VP of the US-based drug discovery organization. In 1989, Dr. Gage joined Genetics Institute, Inc. serving as head of R&D and then president in 1997. In 1998, he was named president of Wyeth [Pharmaceuticals] Research, and subsequently SVP of Science and Technology at Wyeth. Since leaving Wyeth in 2002, Dr. Gage has focused on identifying groundbreaking drug discovery and drug development ventures and helping management teams build these ventures into successful biopharmaceutical companies.
		Matthew J. Mallow is a senior partner at Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates, a New York law firm. As co-head of the firm’s Corporate Finance Group, Mallow represents investment banks and issuers in a variety of financing matters. He has been repeatedly been selected for inclusion in Chambers Global: The World’s Leading Lawyers for Business, Chambers USA: America’s Leading Lawyers for Business and The Best Lawyers in America. Mallow has been a trustee at Brown University since 1990. He is also the chair of the Committee on Securities regulation of the Association of the Bar of the City of New York, and a trustee of the SEC Historical Society.
		Patricia K. Robertson co-founded NanoDrop Technologies, Inc. (now a subsidiary of ThermoFisher Scientific) in 2000. She served as the company’s Director of Finance and Director of Human Resources before retiring in 2008. NanoDrop manufactures photometric instruments that utilize a patented sample-retention process that revolutionized the measurement of small-volume liquid samples in biotech laboratories.

MBL Trustees have reappointed the following Board members to second terms: Kenneth E. Johns, Douglas A. Melton, Charles M. Rosenthal, and James A. Sharp (Class of 2012).

Board of Trustees Officers include Joan Ruderman, President of the Corporation; John W. Rowe, Chairman of the Board; Charles M. Rosenthal, Vice Chair of the Board; and Christopher M. Weld, Clerk. Ex officio members include Gary G. Borisy, MBL Director and CEO; Mary B. Conrad, Treasurer of the Corporation; and Donald Faber, Science Council Chair. Honorary Trustees include Robert E. Mainer, Sheldon J. Segal, and William T. Speck.

The MBL is a leading international, independent, nonprofit institution dedicated to discovery and to improving the human condition through creative research and education in the biological, biomedical and environmental sciences. Founded in 1888 as the Marine Biological Laboratory, the MBL is the oldest private marine laboratory in the Western Hemisphere. For more information, visit www.MBL.edu.